Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

NCT06173219 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

COMBINATION_PRODUCT: Radiotherapy combined with immunotherapy

Sponsor

China-Japan Friendship Hospital